Morgan, Lewis & Bockius LLP advises biotech, medical devices, and pharma clients, with notable strength in transactional matters, including M&A, collaboration, and financing. The firm also handles regulatory matters and IP, including due diligence and litigation. The practice is led by Washington DC’s Michele Buenafe, experienced in medical devices and digital health regulations, compliance, and enforcement. Also in DC, Kathleen Sanzo is a regulatory and compliance issues expert, with Princeton’s Alan Leeds negotiating transactions and complex collaborations. Both Chicago-based, Michael Abernathy focuses on patent, trade secret, and antitrust litigation, whereas Christopher Betti concentrates on IP prosecution and portfolio management. Both in Chicago and San Francisco is Benjamin Pensak, working on collaborations such as acquisitions, licensing, and joint ventures. Litigator Brian Shaffer and corporate ethics and compliance expert Amy Schuh are both in Philadelphia. Stephen Forster joined the DC office from an in-house role, focusing on compliance counseling and transactions related to drug pricing. Arriving from Orrick, Herrington & Sutcliffe LLP is Boston-based Stephen Hall, a trial lawyer and litigator focused on commercial disputes and product liability.
Legal 500 redaktioneller Kommentar
Anwält*innen
Leading partners
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Kathleen Sanzo
Next Generation Partners
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Benjamin Pensak
Praxisleitung
Michele Buenafe, Ben Pensak, Kathleen Sanzo, Michael Abernathy, Alan Leeds, Amy Schuh, Brian Shaffer, Christopher Betti
Weitere Kernanwält*innen
Stephen Hall; Stephen Forster
